» Articles » PMID: 15771591

Cell Biology of Antigen Processing in Vitro and in Vivo

Overview
Date 2005 Mar 18
PMID 15771591
Citations 460
Authors
Affiliations
Soon will be listed here.
Abstract

The conversion of exogenous and endogenous proteins into immunogenic peptides recognized by T lymphocytes involves a series of proteolytic and other enzymatic events culminating in the formation of peptides bound to MHC class I or class II molecules. Although the biochemistry of these events has been studied in detail, only in the past few years has similar information begun to emerge describing the cellular context in which these events take place. This review thus concentrates on the properties of antigen-presenting cells, especially those aspects of their overall organization, regulation, and intracellular transport that both facilitate and modulate the processing of protein antigens. Emphasis is placed on dendritic cells and the specializations that help account for their marked efficiency at antigen processing and presentation both in vitro and, importantly, in vivo. How dendritic cells handle antigens is likely to be as important a determinant of immunogenicity and tolerance as is the nature of the antigens themselves.

Citing Articles

The multifaceted role of SMAD4 in immune cell function.

Cui X, Song Y, Han J, Yuan Z Biochem Biophys Rep. 2025; 41():101902.

PMID: 39802394 PMC: 11721226. DOI: 10.1016/j.bbrep.2024.101902.


Towards designing improved cancer immunotherapy targets with a peptide-MHC-I presentation model, HLApollo.

Thrift W, Lounsbury N, Broadwell Q, Heidersbach A, Freund E, Abdolazimi Y Nat Commun. 2024; 15(1):10752.

PMID: 39737928 PMC: 11686168. DOI: 10.1038/s41467-024-54887-7.


Simultaneous enhancement of cellular and humoral immunity by the lymph node-targeted cholesterolized TLR7 agonist liposomes.

Wan D, Bai Z, Zhang Y, Chen L, Que H, Lan T Acta Pharm Sin B. 2024; 14(10):4577-4590.

PMID: 39525596 PMC: 11544185. DOI: 10.1016/j.apsb.2024.06.006.


Large Clostridial Toxins: A Brief Review and Insights into Antigen Design for Veterinary Vaccine Development.

Rodrigues R, Alves M, Bilhalva M, Kremer F, Junior C, Ferreira M Mol Biotechnol. 2024; .

PMID: 39472390 DOI: 10.1007/s12033-024-01303-6.


Nanobodies Outperform Antibodies - Rapid Functionalization with Equal In Vivo Targeting Properties.

Jung C, Fichter M, Oberlander J, Schunke J, Bolduan V, Schneider P Adv Mater. 2024; 36(52):e2412563.

PMID: 39468885 PMC: 11681313. DOI: 10.1002/adma.202412563.